A Phase 2 Study Evaluating Orteronel, An Inhibitor Of Androgen Biosynthesis, In Patients With Androgen Receptor (Ar)-Expressing Metastatic Triple-Negative Breast Cancer (Tnbc)Denise A. Yardley,Robyn R. Young,Kerin B. Adelson,Andrea L. Silber,Michael D. Kommor,Jose E. Najera,Davey B. Daniel,Nancy W. Peacock,Mythili Shastry,John D. Hainsworth,Howard A. BurrisCANCER RESEARCH（2021）引用 4|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
